Novo Nordisk A/S

Copenhagen Stock Exchange NOVO-B.CO

Novo Nordisk A/S Gross Profit Margin for the year ending December 31, 2023: 84.60%

Novo Nordisk A/S Gross Profit Margin is 84.60% for the year ending December 31, 2023, a 0.81% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • Novo Nordisk A/S Gross Profit Margin for the year ending December 31, 2022 was 83.92%, a 0.87% change year over year.
  • Novo Nordisk A/S Gross Profit Margin for the year ending December 31, 2021 was 83.20%, a -0.38% change year over year.
  • Novo Nordisk A/S Gross Profit Margin for the year ending December 31, 2020 was 83.51%, a -0.03% change year over year.
  • Novo Nordisk A/S Gross Profit Margin for the year ending December 31, 2019 was 83.54%, a -0.84% change year over year.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
Loading...
Copenhagen Stock Exchange: NOVO-B.CO

Novo Nordisk A/S

CEO Mr. Lars Fruergaard Jorgensen
IPO Date Jan. 6, 2001
Location Denmark
Headquarters Novo Alle 1
Employees 71,880
Sector Health Care
Industries
Description

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company has a collaboration agreement with Gilead Sciences, Inc.; and research collaboration with Novo Nordisk to discover cell-specific carriers of nucleic acid therapeutics. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Similar companies

BAVA.CO

Bavarian Nordic A/S

USD 26.62

-0.36%

ORSTED.CO

Ørsted A/S

USD 40.61

1.41%

DANSKE.CO

Danske Bank A/S

USD 29.25

0.65%

DSV.CO

DSV A/S

USD 204.21

-1.25%

VWS.CO

Vestas Wind Systems A/S

USD 13.03

-0.41%

StockViz Staff

January 15, 2025

Any question? Send us an email